Bloomin' Brands, Inc. BLMN
10.88 USD +0.65 (+6.35%)
Nov 4, 2026, 10:56 AM EST
10.60 Day range 10.98
5.19 52-week range 12.63
- YTD
- +76.34%
- 1 year
- +57.91%
Analyst view
Price target (mean) 16.58 +52.4% upside
Now 10.88
- Target (low)
- 13.00
- Target (mean)
- 16.58
- Target (high)
- 22.00
Ratings (0m) 13 2 buy · 10 hold · 1 sell
- Strong buy1
- Buy1
- Hold10
- Sell0
- Strong sell1
Recommendation trend
- This month 13
- 1 month ago 12
- 2 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.42781 | 0.35188 – 0.76064 | 0.75 | -43.0% | 1.08B | -9.3% | 13 |
| Next quarter | 0.70512 | 0.60 – 0.87534 | 0.70 | +0.7% | 1.11B | -6.8% | 10 |
| Current year | 1.80 | 1.76 – 1.84 | 2.93 | -38.6% | 4.43B | -5.1% | 13 |
| Next year | 1.93 | 1.51 – 2.40 | 1.80 | +7.2% | 4.22B | -4.8% | 13 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 5, 2024 | Goldman Sachs | Initiated | — | Sell |
| Nov 12, 2024 | JP Morgan | Maintained | Neutral | Neutral |
| Nov 11, 2024 | Raymond James | Downgrade | Outperform | Market Perform |
| Nov 11, 2024 | Barclays | Maintained | Overweight | Overweight |
| Nov 11, 2024 | Piper Sandler | Maintained | Neutral | Neutral |
| Oct 22, 2024 | B of A Securities | Maintained | Neutral | Neutral |
| Oct 22, 2024 | Barclays | Maintained | Overweight | Overweight |
| Aug 19, 2024 | Citigroup | Maintained | Neutral | Neutral |
| Aug 7, 2024 | Deutsche Bank | Maintained | Hold | Hold |
| Aug 7, 2024 | Barclays | Maintained | Overweight | Overweight |
| Aug 7, 2024 | UBS | Maintained | Neutral | Neutral |
| Aug 7, 2024 | BMO Capital | Maintained | Market Perform | Market Perform |
| Jul 16, 2024 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| May 28, 2024 | JP Morgan | Maintained | Neutral | Neutral |
| May 8, 2024 | Barclays | Maintained | Overweight | Overweight |
| May 8, 2024 | BMO Capital | Maintained | Market Perform | Market Perform |
| May 8, 2024 | UBS | Maintained | Neutral | Neutral |
| Feb 26, 2024 | BMO Capital | Maintained | Market Perform | Market Perform |
| Feb 26, 2024 | Barclays | Maintained | Overweight | Overweight |
| Feb 15, 2024 | Citigroup | Maintained | Neutral | Neutral |
| Jan 23, 2024 | JP Morgan | Downgrade | Overweight | Neutral |
| Jan 3, 2024 | Raymond James | Maintained | Outperform | Outperform |
| Jan 3, 2024 | Barclays | Maintained | Overweight | Overweight |
| Nov 7, 2023 | BMO Capital | Maintained | Market Perform | Market Perform |
| Nov 6, 2023 | Piper Sandler | Maintained | Neutral | Neutral |
| Nov 6, 2023 | Barclays | Maintained | Overweight | Overweight |
| Nov 6, 2023 | Raymond James | Downgrade | Strong Buy | Outperform |
| Nov 2, 2023 | UBS | Maintained | Neutral | Neutral |
| Oct 25, 2023 | Citigroup | Maintained | Neutral | Neutral |
| Oct 23, 2023 | Barclays | Maintained | Overweight | Overweight |
